| Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association … PM Seferovic, P Ponikowski, SD Anker, J Bauersachs, O Chioncel, ... European journal of heart failure 21 (10), 1169-1186, 2019 | 728 | 2019 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 540 | 2020 |
| Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E uropean A … J Čelutkienė, R Pudil, T López‐Fernández, J Grapsa, P Nihoyannopoulos, ... European journal of heart failure 22 (9), 1504-1524, 2020 | 330 | 2020 |
| Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016 S von Haehling, MS Anker, SD Anker Journal of cachexia, sarcopenia and muscle 7 (5), 507-509, 2016 | 304 | 2016 |
| Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association … R Pudil, C Mueller, J Čelutkienė, PA Henriksen, D Lenihan, S Dent, ... European journal of heart failure 22 (11), 1966-1983, 2020 | 266 | 2020 |
| Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 S Trump, S Lukassen, MS Anker, RL Chua, J Liebig, L Thürmann, ... Nature Biotechnology 39 (6), 705-716, 2021 | 166 | 2021 |
| Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge P Ameri, M Canepa, MS Anker, Y Belenkov, J Bergler‐Klein, ... European journal of heart failure 20 (5), 879-887, 2018 | 151 | 2018 |
| Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review MS Anker, R Holcomb, M Muscaritoli, S von Haehling, W Haverkamp, ... Journal of cachexia, sarcopenia and muscle 10 (1), 22-34, 2019 | 150 | 2019 |
| Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers MS Anker, U Landmesser, S von Haehling, J Butler, AJS Coats, SD Anker Journal of Cachexia, Sarcopenia and Muscle 12 (1), 9-13, 2021 | 129 | 2021 |
| Cardiac cachexia: hic et nunc G Loncar, J Springer, M Anker, W Doehner, M Lainscak Journal of cachexia, sarcopenia and muscle 7 (3), 246-260, 2016 | 114 | 2016 |
| Heart failure in the last year: progress and perspective D Tomasoni, M Adamo, MS Anker, S von Haehling, AJS Coats, M Metra ESC heart failure 7 (6), 3505-3530, 2020 | 96 | 2020 |
| Muscle wasting as an independent predictor of survival in patients with chronic heart failure S von Haehling, T Garfias Macedo, M Valentova, MS Anker, N Ebner, ... Journal of cachexia, sarcopenia and muscle 11 (5), 1242-1249, 2020 | 96 | 2020 |
| Muscle wasting and sarcopenia in heart failure—the current state of science A Lena, MS Anker, J Springer International Journal of Molecular Sciences 21 (18), 6549, 2020 | 95 | 2020 |
| Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016 M Saitoh, J Ishida, W Doehner, S von Haehling, MS Anker, AJS Coats, ... International journal of cardiology 238, 5-11, 2017 | 92 | 2017 |
| Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non‐small cell lung cancer: results of a prospective cardiovascular long … MS Anker, N Ebner, B Hildebrandt, J Springer, M Sinn, H Riess, SD Anker, ... European journal of heart failure 18 (12), 1524-1534, 2016 | 86 | 2016 |
| Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology. Cancer diagnosis in patients with heart failure: epidemiology, clinical … P Ameri, M Canepa, MS Anker, Y Belenkov, J Bergler-Klein, ... Eur J Heart Fail 20 (5), 879-887, 2018 | 64 | 2018 |
| TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy A Baumgarten, C Bang, A Tschirner, A Engelmann, V Adams, ... International journal of cardiology 168 (2), 1447-1452, 2013 | 61 | 2013 |
| Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology MS Anker, S Von Haehling, J Springer, M Banach, SD Anker International journal of cardiology 162 (2), 73-76, 2013 | 61 | 2013 |
| Anemia in chronic heart failure: can we treat? What to treat? S Von Haehling, MS Anker, EA Jankowska, P Ponikowski, SD Anker Heart failure reviews 17 (2), 203-210, 2012 | 54 | 2012 |
| Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the … SD Anker, MS Usman, MS Anker, J Butler, M Böhm, WT Abraham, ... European Journal of Heart Failure 25 (7), 936-955, 2023 | 52 | 2023 |
